Cancer Cell (journal)

Last updated

History

Cancer Cell was launched in 2002 with the publication of its inaugural issue on February 1, 2002. In an Editorial published in this first issue, Editor-in-Chief Mariana Resnicoff introduced Cancer Cell as "An exciting forum for cancer research". [3] Following in the footsteps of the Cell Press flagship journal Cell, the goal of Cancer Cell was to publish cutting-edge findings in cancer research and to provide great author service by having a team of dedicated scientific editors that hold the highest standards of excellence, editorial consistency, and author service. Li-Kuo Su became Editor-in-Chief in 2003 and is recognized for promoting the journal's growth and establishing it as one of the most reputable cancer research journals. He retired from his editorial activities in 2019. Steve Mao became Cancer Cell's Editor-in-Chief in 2020 after serving as senior editor at Cell and Science.

Changing for a better future editorial

In the April 2020 special issue of Cancer Cell, Steve Mao published the editorial "Changing for a Better Future" [4] delineating his views for the journal. This Editorial reiterated the journal's commitment to scientific excellence and introduced key changes. While Cancer Cell is traditionally considered a journal interested in strong mechanistic studies, the Editorial highlights its interest in translational and clinical studies, as well in discovery papers that scientifically sound and conceptually bold. In line with the Cell Press rebranding strategy launched in 2020, [5] Steve Mao vowed to continue publishing "Science that Inspires". The Editorial also states the editors' commitment to increase communication with its scientific community and authors, as well as to work with authors to improve the revision process of manuscripts under consideration.

Diversity and inclusion efforts

In 2020, Cancer Cell made a number of changes to increase diversity and inclusion of underrepresented minorities in cancer research and oncology. In June 2020, the journal announced the new members of its advisory board (previously editorial board), which includes a higher representation of female scientists (>40%) and physicians (~50%) and higher geographical and ethnic diversity. [6] That same month, the Cell Editorial Team published the editorial "Science has a racism problem", [6] acknowledging the underrepresentation of Black scientists in STEM in the wake of the murders of George Floyd, Breonna Taylor, and Ahmaud Arbery. These events, in conjunction with the anti-immigration policies of the Trump administration in the U.S., led to a Summer of social reckoning in the scientific community. Cancer Cell joined the cancer research and oncology communities and their call for action and change by dedicating its September 2020 issue to the importance of diversity and immigration in cancer research in the U.S. and publishing a series of opinion pieces by scientists and clinicians that represent several minorities (immigrants, Black, Latinx, LGBTQ) and their allies. [7] [8] [9] The journal has also published several articles that address ethnic health disparities and aim to increase the representation of non-Caucasian populations in cancer research and oncology. [10] [11] [12] [13] [14]

As a part of Cell Press, Cancer Cell has supported Black in Cancer and the #BlackInCancerWeek campaign on Twitter. The journal also participated in the creation of the "Rising Black Scientists Award", a cash award granted to one undergraduate student and one graduate student or postdoctoral trainee "meant to break down barriers and create opportunities by providing funds to support professional development". [15]

In January 2021, Cell Press introduced the Inclusion and Diversity Statement, in which authors may choose to disclose information related to how they are increasing their effort to promote genetic diversity in their study subjects, participation of minorities, and balancing gender representation, to name a few. [16]

References

  1. ↑ "Addendum to the cOAlition S Guidance on the Implementation of Plan S | Plan S". www.coalition-s.org.
  2. ↑ "Elsevier expands Open Access options for Cell Press Journals from January 2021". www.elsevier.com.
  3. ↑ Resnicoff, Mariana (February 2002). "An exciting forum for cancer research". Cancer Cell. 1 (1): 1–2. doi: 10.1016/S1535-6108(02)00019-3 .
  4. ↑ Mao, Steve (April 2020). "Changing for a Better Future". Cancer Cell. 37 (4): 423. doi: 10.1016/j.ccell.2020.03.019 . PMID   32289264.
  5. ↑ The Cell Press Team (29 February 2020). "Science that Inspires". Heliyon. 6 (2) e03362. doi: 10.1016/j.heliyon.2020.e03362 . PMC   7052054 . PMID   32140576.
  6. 1 2 "Editorial Board: Cancer Cell". www.cell.com.
  7. ↑ Merad, Miriam; Posey, Avery D.; Olivero, Ofelia; Singh, Pankaj K.; Mouneimne, Ghassan; Li, Lingyin; Wallace, LaShanale M.; Hayes, Tikvah K. (September 2020). "Diversity Is a Strength of Cancer Research in the U.S." Cancer Cell. 38 (3): 297–300. doi: 10.1016/j.ccell.2020.08.018 . PMC   7489360 . PMID   32931736.
  8. ↑ Morin, Pat J.; Wirtz, Denis; Weeraratna, Ashani T. (September 2020). "Completing the Great Unfinished Symphony of Cancer Together: The Importance of Immigrants in Cancer Research". Cancer Cell. 38 (3): 301–305. doi: 10.1016/j.ccell.2020.08.017 . PMC   7489249 . PMID   32931737.
  9. ↑ Aifantis, Iannis; Neel, Benjamin G. (September 2020). "U.S. Biomedical Research Needs More Immigrant Scientists, Not Fewer!". Cancer Cell. 38 (3): 308. doi: 10.1016/j.ccell.2020.08.010 . PMC   7489325 . PMID   32931738.
  10. ↑ Jiang, Yi-Zhou; Ma, Ding; Suo, Chen; Shi, Jinxiu; Xue, Mengzhu; Hu, Xin; Xiao, Yi; Yu, Ke-Da; Liu, Yi-Rong; Yu, Ying; Zheng, Yuanting; Li, Xiangnan; Zhang, Chenhui; Hu, Pengchen; Zhang, Jing; Hua, Qi; Zhang, Jiyang; Hou, Wanwan; Ren, Luyao; Bao, Ding; Li, Bingying; Yang, Jingcheng; Yao, Ling; Zuo, Wen-Jia; Zhao, Shen; Gong, Yue; Ren, Yi-Xing; Zhao, Ya-Xin; Yang, Yun-Song; Niu, Zhenmin; Cao, Zhi-Gang; Stover, Daniel G.; Verschraegen, Claire; Kaklamani, Virginia; Daemen, Anneleen; Benson, John R.; Takabe, Kazuaki; Bai, Fan; Li, Da-Qiang; Wang, Peng; Shi, Leming; Huang, Wei; Shao, Zhi-Ming (March 2019). "Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies". Cancer Cell. 35 (3): 428–440.e5. doi: 10.1016/j.ccell.2019.02.001 . PMID   30853353.
  11. ↑ Carrot-Zhang, Jian; Chambwe, Nyasha; Damrauer, Jeffrey S.; Knijnenburg, Theo A.; Robertson, A. Gordon; Yau, Christina; Zhou, Wanding; Berger, Ashton C.; Huang, Kuan-lin; Newberg, Justin Y.; Mashl, R. Jay; Romanel, Alessandro; Sayaman, Rosalyn W.; Demichelis, Francesca; Felau, Ina; Frampton, Garrett M.; Han, Seunghun; Hoadley, Katherine A.; Kemal, Anab; Laird, Peter W.; Lazar, Alexander J.; Le, Xiuning; Oak, Ninad; Shen, Hui; Wong, Christopher K.; Zenklusen, Jean C.; Ziv, Elad; Cherniack, Andrew D.; Beroukhim, Rameen; Aguet, Francois; Ding, Li; Demchok, John A.; Mensah, Michael K.A.; Caesar-Johnson, Samantha; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Alfoldi, Jessica; Karczewski, Konrad J.; MacArthur, Daniel G.; Meyerson, Matthew; Benz, Christopher; Stuart, Joshua M. (May 2020). "Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer". Cancer Cell. 37 (5): 639–654.e6. doi: 10.1016/j.ccell.2020.04.012 . PMC   7328015 . PMID   32396860.
  12. ↑ Whisenant, Jennifer G.; Trama, Annalisa; Torri, Valter; De Toma, Alessandro; Viscardi, Giuseppe; Cortellini, Alessio; Michielin, Olivier; Barlesi, Fabrice; Dingemans, Anne-Marie C.; Van Meerbeeck, Jan; Pancaldi, Vera; Soo, Ross A.; Leighl, Natasha B.; Peters, Solange; Wakelee, Heather; Garassino, Marina Chiara; Horn, Leora (June 2020). "TERAVOLT: Thoracic Cancers International COVID-19 Collaboration". Cancer Cell. 37 (6): 742–745. doi: 10.1016/j.ccell.2020.05.008 . PMC   7229923 . PMID   32425702.
  13. ↑ Bernabe-Ramirez, Carolina; Velazquez, Ana I.; Olazagasti, Coral; Bergerot, Cristiane Decat; Bergerot, Paulo Gustavo; Soto-Perez-de-Celis, Enrique; Duma, Narjust (November 2020). "The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America". Cancer Cell. 38 (5): 605–608. doi: 10.1016/j.ccell.2020.10.013 . PMC   7553055 . PMID   33098754.
  14. ↑ Schmidt, Andrew L.; Bakouny, Ziad; Bhalla, Sheena; Steinharter, John A.; Tremblay, Douglas A.; Awad, Mark M.; Kessler, Alaina J.; Haddad, Robert I.; Evans, Michelle; Busser, Fiona; Wotman, Michael; Curran, Catherine R.; Zimmerman, Brittney S.; Bouchard, Gabrielle; Jun, Tomi; Nuzzo, Pier V.; Qin, Qian; Hirsch, Laure; Feld, Jonathan; Kelleher, Kaitlin M.; Seidman, Danielle; Huang, Hsin-Hui; Anderson-Keightly, Heather M.; Abou Alaiwi, Sarah; Rosenbloom, Talia D.; Stewart, Penina S.; Galsky, Matthew D.; Choueiri, Toni K.; Doroshow, Deborah B. (December 2020). "Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study". Cancer Cell. 38 (6): 769–770. doi: 10.1016/j.ccell.2020.10.023 . PMC   7609043 . PMID   33176161.
  15. ↑ "Announcing the Rising Black Scientists Awards". www.cell.com.
  16. ↑ Sweet, Deborah J. (January 2021). "New at Cell Press: The Inclusion and Diversity Statement". Cell. 184 (1): 1–2. doi: 10.1016/j.cell.2020.12.019 . PMID   33417857.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.